A new Irish health clinic is set to make ‘fat jabs’ more accessible to those battling obesity. But the top medic leading the ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

For people beginning their weight loss journey, a combination of physical activity and a healthy diet – such as the ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

New data from The Ohio State University Wexner Medical Center Comprehensive Transplant Center shows obese patients with end stage kidney disease and diabetes can safely use weight loss injections to ...

Glucagon-like peptide-1 receptor (GLP-1R) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors represent 2 distinct classes of incretin-based therapies used for the treatment of type 2 diabetes ...

Medicine, lifestyle changes, and surgery can return glucose levels to normal or nearly normal in some type 2 diabetes ...

Most individuals with chronic kidney disease (CKD) are unaware of their disease, according to a KDIGO controversies conference on CKD prevention.